Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

FLASH2 Study opens patient enrollment PRINCETON, N.J., Dec. 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused ...

Research shows that certain foods and ingredients can trigger acne symptoms. Here is a list of foods associated with skin ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

Researchers Develop Nanofiber Patch for Treatment of Psoriasis Nov. 12 ... which was trained on data from 53,601 skin lesions from 25,105 patients, outperforming existing ...

The acne lesions characteristic of Behçet's syndrome are not sterile and are commonly observed in combination with arthritis. The two main nodular skin lesions—superficial thrombophlebitis and ...

Hand, foot and mouth disease (HFMD) is a very common viral infection that predominantly affects children under the age of 5, ...

Erythromycin: This antibiotic is used for several types of infections, including skin and pneumonia.

The battle against skin cancer in Australia has taken a promising turn with the development of a groundbreaking microneedle ...

20 “Despite currently available treatment options, atopic dermatitis continues to have a massive impact worldwide, with patients not only burdened by intense itch and recurrent skin lesions, but also ...